Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by Karen Busse and NHC Center for Continuing Medical Education. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Karen Busse and NHC Center for Continuing Medical Education or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Pediatric Obesity: The Role of GLP – 1 Receptors

29:28
 
Share
 

Manage episode 476903016 series 2794740
Content provided by Karen Busse and NHC Center for Continuing Medical Education. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Karen Busse and NHC Center for Continuing Medical Education or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

Episode 77: Pediatric Obesity: The Role of GLP – 1 Receptors

Evaluation and Credit: https://www.surveymonkey.com/r/medchat77

Target Audience This activity is targeted toward primary care physicians and advanced providers.

Statement of Need This podcast will address the role of GLP – receptors in the treatment of pediatric obesity. As the prevalence of pediatric obesity is on the rise, the need for effective, evidence-based treatments is essential. This increase in pediatric obesity is associated with numerous health complications for the pediatric patient including type 2 diabetes, hypertension and cardiovascular diseases. Early intervention in the pediatric patient and management can prevent the progression of obesity with the goal of improving the long-term health of these individuals.

Objectives

  • Define pediatric obesity.
  • Discuss the key aspects of GLP – 1 receptors and their use of treatment of the pediatric patient.
  • Explain the mechanisms and criteria for patient selection for GLP – 1 as a treatment option for obesity.
  • Describe best practices integrating GLP-1 receptor agnostic into a broader treatment plan and appropriate monitoring and follow-up.

ModeratorMark McDonald, M.D., MHA, CPE System Vice President Pediatric Medical Affairs Medical Director, Norton Children’s Louisville, Kentucky

Professor Department of Pediatrics Division of Critical Care UofL School of Medicine Louisville, Kentucky

SpeakerSara Watson, M.D. Pediatric Endocrinologist Medical Director of the Type 2 Diabetes Program and the Health Weight Program Norton Children's Endocrinology Louisville, Kentucky

Moderator and Planner Disclosures The planners, moderator and speaker of this activity do not have any relevant financial relationships with ineligible companies to disclose.

Speaker DisclosureThe speaker, Sara Watson, M.D. discloses a relevant financial relationship with the ineligible company Lilly as a principal investigator. All relevant financial relationships have been mitigated.

Commercial Support There was no commercial support for this activity.

Physician Credits

Accreditation Norton Healthcare is accredited by the Kentucky Medical Association to provide continuing medical education for physicians.

Designation Norton Healthcare designates this enduring material for a maximum of .75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing CreditsNorton Healthcare Institute for Education and Development is approved as a provider of nursing continuing professional development by the South Carolina Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. This continuing professional development activity has been approved for 0.75 ANCC CE contact hours.

In order for nursing participants to obtain credits, they must claim attendance by attesting to the number of hours in attendance. For more information related to nursing credits, contact Sally Sturgeon, DNP, RN, SANE-A, AFN-BC at (502) 446-5889 or [email protected].

Resources for Additional Study/References

Characterizing GLP-1 Receptor Agonist Use in Preadolescent and Adolescent Populations https://pubmed.ncbi.nlm.nih.gov/39412809/

Role of GLP-1 Receptor Agonists in Pediatric Obesity: Benefits, Risks, and Approaches to Patient Selection https://pubmed.ncbi.nlm.nih.gov/33085056/

Date of Original Release | April 2025; Information is current as of the time of recording. Course Termination Date | April 2028 Contact Information | Center for Continuing Medical Education (502) 446-5955 or [email protected]

Also listen to Norton Healthcare’s podcast Stronger After Stroke. This podcast, produced by the Norton Neuroscience Institute, discusses difficult topics, answers frequently asked questions and provides survivor stories that provide hope.

Norton Healthcare, a not for profit health care system, is a leader in serving adult and pediatric patients throughout Greater Louisville, Southern Indiana, the commonwealth of Kentucky and beyond. More information about Norton Healthcare is available at NortonHealthcare.com.

  continue reading

53 episodes

Artwork
iconShare
 
Manage episode 476903016 series 2794740
Content provided by Karen Busse and NHC Center for Continuing Medical Education. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Karen Busse and NHC Center for Continuing Medical Education or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

Episode 77: Pediatric Obesity: The Role of GLP – 1 Receptors

Evaluation and Credit: https://www.surveymonkey.com/r/medchat77

Target Audience This activity is targeted toward primary care physicians and advanced providers.

Statement of Need This podcast will address the role of GLP – receptors in the treatment of pediatric obesity. As the prevalence of pediatric obesity is on the rise, the need for effective, evidence-based treatments is essential. This increase in pediatric obesity is associated with numerous health complications for the pediatric patient including type 2 diabetes, hypertension and cardiovascular diseases. Early intervention in the pediatric patient and management can prevent the progression of obesity with the goal of improving the long-term health of these individuals.

Objectives

  • Define pediatric obesity.
  • Discuss the key aspects of GLP – 1 receptors and their use of treatment of the pediatric patient.
  • Explain the mechanisms and criteria for patient selection for GLP – 1 as a treatment option for obesity.
  • Describe best practices integrating GLP-1 receptor agnostic into a broader treatment plan and appropriate monitoring and follow-up.

ModeratorMark McDonald, M.D., MHA, CPE System Vice President Pediatric Medical Affairs Medical Director, Norton Children’s Louisville, Kentucky

Professor Department of Pediatrics Division of Critical Care UofL School of Medicine Louisville, Kentucky

SpeakerSara Watson, M.D. Pediatric Endocrinologist Medical Director of the Type 2 Diabetes Program and the Health Weight Program Norton Children's Endocrinology Louisville, Kentucky

Moderator and Planner Disclosures The planners, moderator and speaker of this activity do not have any relevant financial relationships with ineligible companies to disclose.

Speaker DisclosureThe speaker, Sara Watson, M.D. discloses a relevant financial relationship with the ineligible company Lilly as a principal investigator. All relevant financial relationships have been mitigated.

Commercial Support There was no commercial support for this activity.

Physician Credits

Accreditation Norton Healthcare is accredited by the Kentucky Medical Association to provide continuing medical education for physicians.

Designation Norton Healthcare designates this enduring material for a maximum of .75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing CreditsNorton Healthcare Institute for Education and Development is approved as a provider of nursing continuing professional development by the South Carolina Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. This continuing professional development activity has been approved for 0.75 ANCC CE contact hours.

In order for nursing participants to obtain credits, they must claim attendance by attesting to the number of hours in attendance. For more information related to nursing credits, contact Sally Sturgeon, DNP, RN, SANE-A, AFN-BC at (502) 446-5889 or [email protected].

Resources for Additional Study/References

Characterizing GLP-1 Receptor Agonist Use in Preadolescent and Adolescent Populations https://pubmed.ncbi.nlm.nih.gov/39412809/

Role of GLP-1 Receptor Agonists in Pediatric Obesity: Benefits, Risks, and Approaches to Patient Selection https://pubmed.ncbi.nlm.nih.gov/33085056/

Date of Original Release | April 2025; Information is current as of the time of recording. Course Termination Date | April 2028 Contact Information | Center for Continuing Medical Education (502) 446-5955 or [email protected]

Also listen to Norton Healthcare’s podcast Stronger After Stroke. This podcast, produced by the Norton Neuroscience Institute, discusses difficult topics, answers frequently asked questions and provides survivor stories that provide hope.

Norton Healthcare, a not for profit health care system, is a leader in serving adult and pediatric patients throughout Greater Louisville, Southern Indiana, the commonwealth of Kentucky and beyond. More information about Norton Healthcare is available at NortonHealthcare.com.

  continue reading

53 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play